Literature DB >> 8913485

Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract.

S J van den Hazel1, X H de Vries, P Speelman, J Dankert, G N Tytgat, K Huibregtse, D J van Leeuwen.   

Abstract

Biliary excretion of ciprofloxacin and piperacillin was determined in cholestatic patients who had undergone endoscopic cholangiography. The median concentration of ciprofloxacin (n = 9) was 2.36 micrograms/ml (range, 0.29 to 19.8 micrograms/ml) in bile compared with 1.66 micrograms/ml (range, 0.73 to 2.69 micrograms/ml) in serum. The median concentration of piperacillin (n = 7) was < 5 micrograms/ml (range, < 5 to 26) in bile compared with 14.3 micrograms/ml (range, 5.3 to 80) in serum. Ciprofloxacin, but not piperacillin, can be actively excreted into bile in the presence of a biliary tract obstruction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913485      PMCID: PMC163596     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids.

Authors:  G J Krol; G W Beck; T Benham
Journal:  J Pharm Biomed Anal       Date:  1995-12       Impact factor: 3.935

2.  Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction.

Authors:  J U Levi; O V Martinez; T I Malinin; R Zeppa; A Livingstone; D Hutson; P Calhoun
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

3.  Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans.

Authors:  H Tanimura; S Tominaga; F Rai; H Matsumoto
Journal:  Arzneimittelforschung       Date:  1986-09

4.  Biliary excretion of aztreonam in patients with biliary tract disease.

Authors:  O V Martinez; J U Levi; R G Devlin
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

5.  Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice.

Authors:  J I Blenkharn; N Habib; D Mok; L John; G A McPherson; R N Gibson; L H Blumgart; I S Benjamin
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

6.  Experimental studies of biliary excretion of piperacillin.

Authors:  P Calhoun; K B Brown; R Strunk; D A Krusch; W M Scheld; J B Hanks
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

7.  Clinical and microbiological evaluation of piperacillin in elective biliary surgery.

Authors:  D L Morris; Z J Mojaddedi; D W Burdon; M R Keighley
Journal:  J Hosp Infect       Date:  1983-06       Impact factor: 3.926

8.  Concentrations of ciprofloxacin in human liver, gallbladder, and bile after oral administration.

Authors:  M Dan; N Verbin; A Gorea; H Nagar; S A Berger
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  Piperacillin distribution into bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue in surgical patients.

Authors:  J Russo; M I Thompson; M E Russo; B A Saxon; J M Matsen; F G Moody; L F Rikkers
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

10.  Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.

Authors:  T Bergan; S B Thorsteinsson; R Solberg; L Bjornskau; I M Kolstad; S Johnsen
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

View more
  8 in total

1.  Antimicrobial management of intra-abdominal infections: literature's guidelines.

Authors:  Massimo Sartelli; Fausto Catena; Federico Coccolini; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.

Authors:  Atsushi Tanaka; Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Masahiro Yoshida; Fumihiko Miura; Masahiko Hirota; Keita Wada; Toshihiko Mayumi; Harumi Gomi; Joseph S Solomkin; Steven M Strasberg; Henry A Pitt; Jacques Belghiti; Eduardo de Santibanes; Robert Padbury; Miin-Fu Chen; Giulio Belli; Chen-Guo Ker; Serafin C Hilvano; Sheung-Tat Fan; Kui-Hin Liau
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

Review 3.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

Review 4.  Biliary tract infections: a guide to drug treatment.

Authors:  J F Westphal; J M Brogard
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

5.  In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis.

Authors:  Andreas Weber; Wolfgang Huber; Klaus Kamereck; Philipp Winkle; Petra Voland; Hans Weidenbach; Roland M Schmid; Christian Prinz
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

6.  2013 WSES guidelines for management of intra-abdominal infections.

Authors:  Massimo Sartelli; Pierluigi Viale; Fausto Catena; Luca Ansaloni; Ernest Moore; Mark Malangoni; Frederick A Moore; George Velmahos; Raul Coimbra; Rao Ivatury; Andrew Peitzman; Kaoru Koike; Ari Leppaniemi; Walter Biffl; Clay Cothren Burlew; Zsolt J Balogh; Ken Boffard; Cino Bendinelli; Sanjay Gupta; Yoram Kluger; Ferdinando Agresta; Salomone Di Saverio; Imtiaz Wani; Alex Escalona; Carlos Ordonez; Gustavo P Fraga; Gerson Alves Pereira Junior; Miklosh Bala; Yunfeng Cui; Sanjay Marwah; Boris Sakakushev; Victor Kong; Noel Naidoo; Adamu Ahmed; Ashraf Abbas; Gianluca Guercioni; Nereo Vettoretto; Rafael Díaz-Nieto; Ihor Gerych; Cristian Tranà; Mario Paulo Faro; Kuo-Ching Yuan; Kenneth Yuh Yen Kok; Alain Chichom Mefire; Jae Gil Lee; Suk-Kyung Hong; Wagih Ghnnam; Boonying Siribumrungwong; Norio Sato; Kiyoshi Murata; Takayuki Irahara; Federico Coccolini; Helmut A Segovia Lohse; Alfredo Verni; Tomohisa Shoko
Journal:  World J Emerg Surg       Date:  2013-01-08       Impact factor: 5.469

7.  WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.

Authors:  Massimo Sartelli; Pierluigi Viale; Kaoru Koike; Federico Pea; Fabio Tumietto; Harry van Goor; Gianluca Guercioni; Angelo Nespoli; Cristian Tranà; Fausto Catena; Luca Ansaloni; Ari Leppaniemi; Walter Biffl; Frederick A Moore; Renato Poggetti; Antonio Daniele Pinna; Ernest E Moore
Journal:  World J Emerg Surg       Date:  2011-01-13       Impact factor: 5.469

8.  Isolated microorganisms in plastic biliary stents placed for benign and malignant diseases.

Authors:  Paris Basioukas; Antonios Vezakis; Olympia Zarkotou; Georgios Fragulidis; Katerina Themeli-Digalaki; Spyros Rizos; Andreas Polydorou
Journal:  Ann Gastroenterol       Date:  2014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.